Evidence map›Paper›PMID 42789330›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026

NR4A1-Driven Granulosa Cell Ferroptosis Contributes to Obesity-Related Ovarian Dysfunction and Metformin-Mediated Ovarian Protection.

Huihui Wang, Chaoying Wang, Shuaishuai Guo, Guang Yang, Junnan Fang, Jingyi Hu, Ran Jiang, Jun Zhai, Haixia Jin, Wenyan Song and 8 more

Abstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Huihui WangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chaoying WangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shuaishuai GuoCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Guang YangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Junnan FangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jingyi HuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ran JiangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jun ZhaiCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Haixia JinCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenyan SongCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Senlin ShiCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xianju HuangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lin QiCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhaoting WuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yan LiuCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Ning SongCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiangyang ZhangCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Guidong YaoCenter for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0000-0002-7174-9989

Funding

| Key Scientific Research Project of Colleges and Universities in Henan Province 26A320024| National Natural Science Foundation of China-Henan Joint Fund (-) U1904138| Natural Science Foundation of Henan Province (Henan Natural Science Foundation) 262300421646Open Research Fund of the National Health Commission Key Laboratory of Birth Defects Prevention NHCKLBDP202407Provincial and Ministerial Co-construction Project of Henan Medical Science and Technology Program SBGJ202502063
6 · The paper itself

Abstract

Obesity triggers ovarian dysfunction and female infertility accompanied by granulosa cell damage. Ferroptosis, iron-dependent lipid peroxidation-mediated cell death, participates in multiple reproductive diseases, yet the molecular cascade linking metabolic obesity to granulosa ferroptosis remains undefined. Using high-fat diet obese mice, primary human granulosa cells from obese infertile patients, and KGN cell lines, we identified the nuclear receptor NR4A1 as a key mediator of obesity-induced ferroptosis downstream of PI3K/AKT signaling. Elevated NR4A1 was associated with upregulated ACSL4 and suppressed GPX4, accompanied by iron overload, lipid peroxidation, and mitochondrial collapse, impairing folliculogenesis and oocyte quality. Metformin reduced NR4A1 activation in association with PI3K/AKT signaling modulation, thereby attenuating ferroptotic injury and contributing to the restoration of ovarian function. In vivo NR4A1 agonist administration attenuated the protective effects of metformin, while ovarian-specific NR4A1 knockdown alleviated HFD-triggered ovarian ferroptosis. Single-cell RNA-seq further suggested that metformin remodels oocyte redox and folliculogenic transcriptional networks. These findings support a role for the PI3K/AKT-NR4A1 signaling pathway in driving ferroptosis during obesity-related ovarian dysfunction and suggest a potential anti-ferroptotic mechanism of metformin in this context.

Indexed as

FerroptosisGranulosa CellsMetforminNuclear Receptor Subfamily 4, Group A, Member 1ObesityOvarian DiseasesOvaryAnimalsCoenzyme A LigasesDiet, High-FatFemaleHumansInfertility, FemaleLipid PeroxidationMiceMice, Inbred C57BLAcsl4 protein, mouseCoenzyme A LigasesMetforminNR4A1 protein, humanNr4a1 protein, mouseNuclear Receptor Subfamily 4, Group A, Member 1Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktferroptosisgranulosa cellmetforminNR4A1obesityovarian dysfunctionoxidative stress

Identifiers

PMID42789330
PMCPMC13614481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.